These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

536 related articles for article (PubMed ID: 19442446)

  • 1. Transdermal fentanyl in cachectic cancer patients.
    Heiskanen T; Mätzke S; Haakana S; Gergov M; Vuori E; Kalso E
    Pain; 2009 Jul; 144(1-2):218-22. PubMed ID: 19442446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of transdermal fentanyl without prior opioid stabilization in patients with cancer pain.
    Tawfik MO; Bryuzgin V; Kourteva G;
    Curr Med Res Opin; 2004 Mar; 20(3):259-67. PubMed ID: 15025835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved cancer pain treatment using combined fentanyl-TTS and tramadol.
    Marinangeli F; Ciccozzi A; Aloisio L; Colangeli A; Paladini A; Bajocco C; Coaccioli S; Varrassi G
    Pain Pract; 2007 Dec; 7(4):307-12. PubMed ID: 17986161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of local administration of transdermal fentanyl on peripheral opioid analgesia.
    Worrich S; Schuler G; Janicki PK
    Pain Med; 2007; 8(1):41-7. PubMed ID: 17244103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Phase III study to assess the clinical utility of low-dose fentanyl transdermal system in patients with chronic nonmalignant pain.
    Otis J; Rothman M
    Curr Med Res Opin; 2006 Aug; 22(8):1493-501. PubMed ID: 16870074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inter- and intra-individual variability in transdermal fentanyl absorption in cancer pain patients.
    Solassol I; Caumette L; Bressolle F; Garcia F; Thézenas S; Astre C; Culine S; Coulouma R; Pinguet F
    Oncol Rep; 2005 Oct; 14(4):1029-36. PubMed ID: 16142368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A safe and effective method for converting patients from transdermal to intravenous fentanyl for the treatment of acute cancer-related pain.
    Kornick CA; Santiago-Palma J; Schulman G; O'Brien PC; Weigand S; Payne R; Manfredi PL
    Cancer; 2003 Jun; 97(12):3121-4. PubMed ID: 12784350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized, open, parallel group, multicenter trial to investigate analgesic efficacy and safety of a new transdermal fentanyl patch compared to standard opioid treatment in cancer pain.
    Kress HG; Von der Laage D; Hoerauf KH; Nolte T; Heiskanen T; Petersen R; Lundorff L; Sabatowski R; Krenn H; Rosland JH; Saedder EA; Jensen NH
    J Pain Symptom Manage; 2008 Sep; 36(3):268-79. PubMed ID: 18538974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors influencing quality of life in cancer patients: the role of transdermal fentanyl in the management of pain.
    Payne R
    Semin Oncol; 1998 Jun; 25(3 Suppl 7):47-53. PubMed ID: 9671331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Equipotent doses of transdermal fentanyl and transdermal buprenorphine in patients with cancer and noncancer pain: results of a retrospective cohort study.
    Sittl R; Likar R; Nautrup BP
    Clin Ther; 2005 Feb; 27(2):225-37. PubMed ID: 15811486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in the prescribed daily doses of transdermal fentanyl and transdermal buprenorphine during treatment of patients with cancer and noncancer pain in Germany: results of a retrospective cohort study.
    Sittl R; Nuijten M; Nautrup BP
    Clin Ther; 2005 Jul; 27(7):1022-31. PubMed ID: 16154481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors predicting requirement of high-dose transdermal fentanyl in opioid switching from oral morphine or oxycodone in patients with cancer pain.
    Kanbayashi Y; Hosokawa T; Okamoto K; Fujimoto S; Konishi H; Otsuji E; Yoshikawa T; Takagi T; Miki T; Taniwaki M
    Clin J Pain; 2011 Oct; 27(8):664-7. PubMed ID: 21471811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical experience with transdermal and orally administered opioids in palliative care patients--a retrospective study.
    Clemens KE; Klaschik E
    Jpn J Clin Oncol; 2007 Apr; 37(4):302-9. PubMed ID: 17519302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of transdermal fentanyl treatment on serum cortisol concentrations in patients with non-cancer pain.
    Ozyuvaci E; Yanmaz Alnigenis N; Altan A
    J Pain Symptom Manage; 2004 Sep; 28(3):277-81. PubMed ID: 15336341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum concentration of fentanyl during conversion from intravenous to transdermal administration to patients with chronic cancer pain.
    Nomura M; Inoue K; Matsushita S; Takahari D; Kondoh C; Shitara K; Ura T; Hayashi K; Kojima H; Kamata M; Tatematsu M; Hosoda R; Sawada S; Oka H; Muro K
    Clin J Pain; 2013 Jun; 29(6):487-91. PubMed ID: 23328324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Transdermal fentanyl for the management of cancer pain: a survey of 4492 patients].
    Yu SY; Sun Y; Wu YL; Qin SK; Xie GR; Liu SJ; Sui GJ; Zhang HC
    Zhonghua Zhong Liu Za Zhi; 2005 Jun; 27(6):369-72. PubMed ID: 16117902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sustained-release oral morphine versus transdermal fentanyl and oral methadone in cancer pain management.
    Mercadante S; Porzio G; Ferrera P; Fulfaro F; Aielli F; Verna L; Villari P; Ficorella C; Gebbia V; Riina S; Casuccio A; Mangione S
    Eur J Pain; 2008 Nov; 12(8):1040-6. PubMed ID: 18353696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opioid switching from transdermal fentanyl to oral methadone in patients with cancer pain.
    Benítez-Rosario MA; Feria M; Salinas-Martín A; Martínez-Castillo LP; Martín-Ortega JJ
    Cancer; 2004 Dec; 101(12):2866-73. PubMed ID: 15529307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Transdermal fentanyl in treating severe painful mucositis caused by autologous hematopoietic stem cell transplantation].
    Huang HQ; Cai QQ; Lin XB; Wang BF; Bu Q; Gao Y; Peng YL
    Ai Zheng; 2007 Apr; 26(4):390-3. PubMed ID: 17430658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Research from the Palliative Care Department in Poznań on treatment of neoplasm pain with Durogesic (transdermal fentanyl)].
    Leppert W; Luczak J; Gorzelińska L; Kozikowska J
    Przegl Lek; 2000; 57(1):59-64. PubMed ID: 10907375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.